Japan Production Value by Application and Therapeutic Category: Yearly
Production Value: Require guidance or OTC Drug: Agent for Dental and Oral Use
Production Value: Require guidance or OTC Drug: Agent for Dental and Oral Use data was reported at 12,402,845.000 JPY th in 2022. This records an increase from the previous number of 10,782,043.000 JPY th for 2021. Production Value: Require guidance or OTC Drug: Agent for Dental and Oral Use data is updated yearly, averaging 12,569,771.000 JPY th from Dec 2019 (Median) to 2022, with 4 observations. The data reached an all-time high of 12,886,221.000 JPY th in 2019 and a record low of 10,782,043.000 JPY th in 2021. Production Value: Require guidance or OTC Drug: Agent for Dental and Oral Use data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT008: Production Value by Application and Therapeutic Category: Yearly.
| Last | Frequency | Range |
|---|---|---|
| 12,402,845.000 2022 | yearly | 2019 - 2022 |
View Japan's Production Value: Require guidance or OTC Drug: Agent for Dental and Oral Use from 2019 to 2022 in the chart:
Production Value: Require guidance or OTC Drug: Allergy Drug
Production Value: Require guidance or OTC Drug: Allergy Drug data was reported at 10,032,072.000 JPY th in 2022. This records an increase from the previous number of 8,483,424.000 JPY th for 2021. Production Value: Require guidance or OTC Drug: Allergy Drug data is updated yearly, averaging 9,414,032.500 JPY th from Dec 2019 (Median) to 2022, with 4 observations. The data reached an all-time high of 11,344,072.000 JPY th in 2019 and a record low of 8,483,424.000 JPY th in 2021. Production Value: Require guidance or OTC Drug: Allergy Drug data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT008: Production Value by Application and Therapeutic Category: Yearly.
| Last | Frequency | Range |
|---|---|---|
| 10,032,072.000 2022 | yearly | 2019 - 2022 |
View Japan's Production Value: Require guidance or OTC Drug: Allergy Drug from 2019 to 2022 in the chart:
Production Value: Require guidance or OTC Drug: Blood and Body Fluids Drug
Production Value: Require guidance or OTC Drug: Blood and Body Fluids Drug data was reported at 19,202.000 JPY th in 2022. This records a decrease from the previous number of 37,449.000 JPY th for 2021. Production Value: Require guidance or OTC Drug: Blood and Body Fluids Drug data is updated yearly, averaging 27,955.500 JPY th from Dec 2019 (Median) to 2022, with 4 observations. The data reached an all-time high of 37,449.000 JPY th in 2021 and a record low of 17,316.000 JPY th in 2020. Production Value: Require guidance or OTC Drug: Blood and Body Fluids Drug data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT008: Production Value by Application and Therapeutic Category: Yearly.
| Last | Frequency | Range |
|---|---|---|
| 19,202.000 2022 | yearly | 2019 - 2022 |
View Japan's Production Value: Require guidance or OTC Drug: Blood and Body Fluids Drug from 2019 to 2022 in the chart:
Production Value: Require guidance or OTC Drug: Cardiovascular Preparation
Production Value: Require guidance or OTC Drug: Cardiovascular Preparation data was reported at 8,283,605.000 JPY th in 2022. This records a decrease from the previous number of 8,441,621.000 JPY th for 2021. Production Value: Require guidance or OTC Drug: Cardiovascular Preparation data is updated yearly, averaging 8,809,168.000 JPY th from Dec 2019 (Median) to 2022, with 4 observations. The data reached an all-time high of 12,569,978.000 JPY th in 2019 and a record low of 8,283,605.000 JPY th in 2022. Production Value: Require guidance or OTC Drug: Cardiovascular Preparation data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT008: Production Value by Application and Therapeutic Category: Yearly.
| Last | Frequency | Range |
|---|---|---|
| 8,283,605.000 2022 | yearly | 2019 - 2022 |
View Japan's Production Value: Require guidance or OTC Drug: Cardiovascular Preparation from 2019 to 2022 in the chart:
Production Value: Require guidance or OTC Drug: Cell Activation Drug
Production Value: Require guidance or OTC Drug: Cell Activation Drug data was reported at 1,122,127.000 JPY th in 2022. This records a decrease from the previous number of 1,239,409.000 JPY th for 2021. Production Value: Require guidance or OTC Drug: Cell Activation Drug data is updated yearly, averaging 1,185,814.500 JPY th from Dec 2019 (Median) to 2022, with 4 observations. The data reached an all-time high of 1,239,409.000 JPY th in 2021 and a record low of 1,122,127.000 JPY th in 2022. Production Value: Require guidance or OTC Drug: Cell Activation Drug data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT008: Production Value by Application and Therapeutic Category: Yearly.
| Last | Frequency | Range |
|---|---|---|
| 1,122,127.000 2022 | yearly | 2019 - 2022 |
View Japan's Production Value: Require guidance or OTC Drug: Cell Activation Drug from 2019 to 2022 in the chart:
Production Value: Require guidance or OTC Drug: Central Nervous System Agent
Production Value: Require guidance or OTC Drug: Central Nervous System Agent data was reported at 121,269,738.000 JPY th in 2022. This records an increase from the previous number of 115,937,480.000 JPY th for 2021. Production Value: Require guidance or OTC Drug: Central Nervous System Agent data is updated yearly, averaging 130,375,500.500 JPY th from Dec 2019 (Median) to 2022, with 4 observations. The data reached an all-time high of 143,493,520.000 JPY th in 2020 and a record low of 115,937,480.000 JPY th in 2021. Production Value: Require guidance or OTC Drug: Central Nervous System Agent data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT008: Production Value by Application and Therapeutic Category: Yearly.
| Last | Frequency | Range |
|---|---|---|
| 121,269,738.000 2022 | yearly | 2019 - 2022 |
View Japan's Production Value: Require guidance or OTC Drug: Central Nervous System Agent from 2019 to 2022 in the chart:
Production Value: Require guidance or OTC Drug: Chemotherapeutics
Production Value: Require guidance or OTC Drug: Chemotherapeutics data was reported at 307,086.000 JPY th in 2022. This records a decrease from the previous number of 335,594.000 JPY th for 2021. Production Value: Require guidance or OTC Drug: Chemotherapeutics data is updated yearly, averaging 378,116.000 JPY th from Dec 2019 (Median) to 2022, with 4 observations. The data reached an all-time high of 537,251.000 JPY th in 2019 and a record low of 307,086.000 JPY th in 2022. Production Value: Require guidance or OTC Drug: Chemotherapeutics data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT008: Production Value by Application and Therapeutic Category: Yearly.
| Last | Frequency | Range |
|---|---|---|
| 307,086.000 2022 | yearly | 2019 - 2022 |
View Japan's Production Value: Require guidance or OTC Drug: Chemotherapeutics from 2019 to 2022 in the chart:
Production Value: Require guidance or OTC Drug: Crude Drug
Production Value: Require guidance or OTC Drug: Crude Drug data was reported at 1,055,267.000 JPY th in 2022. This records a decrease from the previous number of 1,998,156.000 JPY th for 2021. Production Value: Require guidance or OTC Drug: Crude Drug data is updated yearly, averaging 1,680,574.000 JPY th from Dec 2019 (Median) to 2022, with 4 observations. The data reached an all-time high of 3,432,367.000 JPY th in 2019 and a record low of 1,055,267.000 JPY th in 2022. Production Value: Require guidance or OTC Drug: Crude Drug data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT008: Production Value by Application and Therapeutic Category: Yearly.
| Last | Frequency | Range |
|---|---|---|
| 1,055,267.000 2022 | yearly | 2019 - 2022 |
View Japan's Production Value: Require guidance or OTC Drug: Crude Drug from 2019 to 2022 in the chart:
Production Value: Require guidance or OTC Drug: Dermatological Drug
Production Value: Require guidance or OTC Drug: Dermatological Drug data was reported at 170,530,645.000 JPY th in 2022. This records a decrease from the previous number of 185,637,006.000 JPY th for 2021. Production Value: Require guidance or OTC Drug: Dermatological Drug data is updated yearly, averaging 176,980,502.500 JPY th from Dec 2019 (Median) to 2022, with 4 observations. The data reached an all-time high of 185,637,006.000 JPY th in 2021 and a record low of 170,530,645.000 JPY th in 2022. Production Value: Require guidance or OTC Drug: Dermatological Drug data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT008: Production Value by Application and Therapeutic Category: Yearly.
| Last | Frequency | Range |
|---|---|---|
| 170,530,645.000 2022 | yearly | 2019 - 2022 |
View Japan's Production Value: Require guidance or OTC Drug: Dermatological Drug from 2019 to 2022 in the chart:
Production Value: Require guidance or OTC Drug: Digestive Organ Agent
Production Value: Require guidance or OTC Drug: Digestive Organ Agent data was reported at 69,580,520.000 JPY th in 2022. This records a decrease from the previous number of 69,857,276.000 JPY th for 2021. Production Value: Require guidance or OTC Drug: Digestive Organ Agent data is updated yearly, averaging 72,573,084.500 JPY th from Dec 2019 (Median) to 2022, with 4 observations. The data reached an all-time high of 79,148,279.000 JPY th in 2019 and a record low of 69,580,520.000 JPY th in 2022. Production Value: Require guidance or OTC Drug: Digestive Organ Agent data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT008: Production Value by Application and Therapeutic Category: Yearly.
| Last | Frequency | Range |
|---|---|---|
| 69,580,520.000 2022 | yearly | 2019 - 2022 |
View Japan's Production Value: Require guidance or OTC Drug: Digestive Organ Agent from 2019 to 2022 in the chart:
Production Value: Require guidance or OTC Drug: Dispensing Drug
Production Value: Require guidance or OTC Drug: Dispensing Drug data was reported at 2,095,025.000 JPY th in 2022. This records an increase from the previous number of 1,951,166.000 JPY th for 2021. Production Value: Require guidance or OTC Drug: Dispensing Drug data is updated yearly, averaging 2,257,607.000 JPY th from Dec 2019 (Median) to 2022, with 4 observations. The data reached an all-time high of 2,657,033.000 JPY th in 2020 and a record low of 1,951,166.000 JPY th in 2021. Production Value: Require guidance or OTC Drug: Dispensing Drug data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT008: Production Value by Application and Therapeutic Category: Yearly.
| Last | Frequency | Range |
|---|---|---|
| 2,095,025.000 2022 | yearly | 2019 - 2022 |
View Japan's Production Value: Require guidance or OTC Drug: Dispensing Drug from 2019 to 2022 in the chart:
Production Value: Require guidance or OTC Drug: Drug based on Other Crude Drug and Chinese Medicine Prescription
Production Value: Require guidance or OTC Drug: Drug based on Other Crude Drug and Chinese Medicine Prescription data was reported at 10,047,896.000 JPY th in 2022. This records an increase from the previous number of 9,431,529.000 JPY th for 2021. Production Value: Require guidance or OTC Drug: Drug based on Other Crude Drug and Chinese Medicine Prescription data is updated yearly, averaging 9,527,595.000 JPY th from Dec 2019 (Median) to 2022, with 4 observations. The data reached an all-time high of 10,047,896.000 JPY th in 2022 and a record low of 9,188,581.000 JPY th in 2020. Production Value: Require guidance or OTC Drug: Drug based on Other Crude Drug and Chinese Medicine Prescription data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT008: Production Value by Application and Therapeutic Category: Yearly.
| Last | Frequency | Range |
|---|---|---|
| 10,047,896.000 2022 | yearly | 2019 - 2022 |
View Japan's Production Value: Require guidance or OTC Drug: Drug based on Other Crude Drug and Chinese Medicine Prescription from 2019 to 2022 in the chart:
Production Value: Require guidance or OTC Drug: Drug for In Vitro Diagnostic
Production Value: Require guidance or OTC Drug: Drug for In Vitro Diagnostic data was reported at 3,102,529.000 JPY th in 2022. This records a decrease from the previous number of 3,347,943.000 JPY th for 2021. Production Value: Require guidance or OTC Drug: Drug for In Vitro Diagnostic data is updated yearly, averaging 3,351,083.000 JPY th from Dec 2019 (Median) to 2022, with 4 observations. The data reached an all-time high of 3,418,047.000 JPY th in 2019 and a record low of 3,102,529.000 JPY th in 2022. Production Value: Require guidance or OTC Drug: Drug for In Vitro Diagnostic data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT008: Production Value by Application and Therapeutic Category: Yearly.
| Last | Frequency | Range |
|---|---|---|
| 3,102,529.000 2022 | yearly | 2019 - 2022 |
View Japan's Production Value: Require guidance or OTC Drug: Drug for In Vitro Diagnostic from 2019 to 2022 in the chart:
Production Value: Require guidance or OTC Drug: Hormones, include Antihormones
Production Value: Require guidance or OTC Drug: Hormones, include Antihormones data was reported at 145,627.000 JPY th in 2022. This records an increase from the previous number of 126,903.000 JPY th for 2021. Production Value: Require guidance or OTC Drug: Hormones, include Antihormones data is updated yearly, averaging 266,521.000 JPY th from Dec 2019 (Median) to 2022, with 4 observations. The data reached an all-time high of 538,684.000 JPY th in 2020 and a record low of 126,903.000 JPY th in 2021. Production Value: Require guidance or OTC Drug: Hormones, include Antihormones data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT008: Production Value by Application and Therapeutic Category: Yearly.
| Last | Frequency | Range |
|---|---|---|
| 145,627.000 2022 | yearly | 2019 - 2022 |
View Japan's Production Value: Require guidance or OTC Drug: Hormones, include Antihormones from 2019 to 2022 in the chart:
Production Value: Require guidance or OTC Drug: Nourishing Tonic
Production Value: Require guidance or OTC Drug: Nourishing Tonic data was reported at 46,978,230.000 JPY th in 2022. This records an increase from the previous number of 43,303,470.000 JPY th for 2021. Production Value: Require guidance or OTC Drug: Nourishing Tonic data is updated yearly, averaging 46,728,488.500 JPY th from Dec 2019 (Median) to 2022, with 4 observations. The data reached an all-time high of 47,285,657.000 JPY th in 2020 and a record low of 43,303,470.000 JPY th in 2021. Production Value: Require guidance or OTC Drug: Nourishing Tonic data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT008: Production Value by Application and Therapeutic Category: Yearly.
| Last | Frequency | Range |
|---|---|---|
| 46,978,230.000 2022 | yearly | 2019 - 2022 |
View Japan's Production Value: Require guidance or OTC Drug: Nourishing Tonic from 2019 to 2022 in the chart:
Production Value: Require guidance or OTC Drug: Other Drug for Individual Organ
Production Value: Require guidance or OTC Drug: Other Drug for Individual Organ data was reported at 3,532.000 JPY th in 2022. This records a decrease from the previous number of 7,064.000 JPY th for 2021. Production Value: Require guidance or OTC Drug: Other Drug for Individual Organ data is updated yearly, averaging 5,200.500 JPY th from Dec 2019 (Median) to 2022, with 4 observations. The data reached an all-time high of 7,064.000 JPY th in 2021 and a record low of 3,337.000 JPY th in 2019. Production Value: Require guidance or OTC Drug: Other Drug for Individual Organ data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT008: Production Value by Application and Therapeutic Category: Yearly.
| Last | Frequency | Range |
|---|---|---|
| 3,532.000 2022 | yearly | 2019 - 2022 |
View Japan's Production Value: Require guidance or OTC Drug: Other Drug for Individual Organ from 2019 to 2022 in the chart:
Production Value: Require guidance or OTC Drug: Other Metabolic Drug
Production Value: Require guidance or OTC Drug: Other Metabolic Drug data was reported at 38,981,977.000 JPY th in 2022. This records an increase from the previous number of 35,332,500.000 JPY th for 2021. Production Value: Require guidance or OTC Drug: Other Metabolic Drug data is updated yearly, averaging 37,913,506.000 JPY th from Dec 2019 (Median) to 2022, with 4 observations. The data reached an all-time high of 43,366,231.000 JPY th in 2019 and a record low of 35,332,500.000 JPY th in 2021. Production Value: Require guidance or OTC Drug: Other Metabolic Drug data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT008: Production Value by Application and Therapeutic Category: Yearly.
| Last | Frequency | Range |
|---|---|---|
| 38,981,977.000 2022 | yearly | 2019 - 2022 |
View Japan's Production Value: Require guidance or OTC Drug: Other Metabolic Drug from 2019 to 2022 in the chart:
Production Value: Require guidance or OTC Drug: Other agents not mainly for therapeutic purpose
Production Value: Require guidance or OTC Drug: Other agents not mainly for therapeutic purpose data was reported at 3,477,392.000 JPY th in 2022. This records a decrease from the previous number of 3,751,882.000 JPY th for 2021. Production Value: Require guidance or OTC Drug: Other agents not mainly for therapeutic purpose data is updated yearly, averaging 3,627,030.000 JPY th from Dec 2019 (Median) to 2022, with 4 observations. The data reached an all-time high of 3,751,882.000 JPY th in 2021 and a record low of 3,477,392.000 JPY th in 2022. Production Value: Require guidance or OTC Drug: Other agents not mainly for therapeutic purpose data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT008: Production Value by Application and Therapeutic Category: Yearly.
| Last | Frequency | Range |
|---|---|---|
| 3,477,392.000 2022 | yearly | 2019 - 2022 |
View Japan's Production Value: Require guidance or OTC Drug: Other agents not mainly for therapeutic purpose from 2019 to 2022 in the chart:
Production Value: Require guidance or OTC Drug: Parasitic Veterinary Drug
Production Value: Require guidance or OTC Drug: Parasitic Veterinary Drug data was reported at 74,029.000 JPY th in 2022. This records an increase from the previous number of 70,527.000 JPY th for 2021. Production Value: Require guidance or OTC Drug: Parasitic Veterinary Drug data is updated yearly, averaging 72,278.000 JPY th from Dec 2019 (Median) to 2022, with 4 observations. The data reached an all-time high of 86,271.000 JPY th in 2020 and a record low of 52,301.000 JPY th in 2019. Production Value: Require guidance or OTC Drug: Parasitic Veterinary Drug data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT008: Production Value by Application and Therapeutic Category: Yearly.
| Last | Frequency | Range |
|---|---|---|
| 74,029.000 2022 | yearly | 2019 - 2022 |
View Japan's Production Value: Require guidance or OTC Drug: Parasitic Veterinary Drug from 2019 to 2022 in the chart:
Production Value: Require guidance or OTC Drug: Peripheral Nervous System Agent
Production Value: Require guidance or OTC Drug: Peripheral Nervous System Agent data was reported at 4,632,208.000 JPY th in 2022. This records an increase from the previous number of 1,785,444.000 JPY th for 2021. Production Value: Require guidance or OTC Drug: Peripheral Nervous System Agent data is updated yearly, averaging 1,240,910.000 JPY th from Dec 2019 (Median) to 2022, with 4 observations. The data reached an all-time high of 4,632,208.000 JPY th in 2022 and a record low of 645,305.000 JPY th in 2019. Production Value: Require guidance or OTC Drug: Peripheral Nervous System Agent data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT008: Production Value by Application and Therapeutic Category: Yearly.
| Last | Frequency | Range |
|---|---|---|
| 4,632,208.000 2022 | yearly | 2019 - 2022 |
View Japan's Production Value: Require guidance or OTC Drug: Peripheral Nervous System Agent from 2019 to 2022 in the chart:
Production Value: Require guidance or OTC Drug: Public Health Drug
Production Value: Require guidance or OTC Drug: Public Health Drug data was reported at 15,913,943.000 JPY th in 2022. This records a decrease from the previous number of 17,963,439.000 JPY th for 2021. Production Value: Require guidance or OTC Drug: Public Health Drug data is updated yearly, averaging 18,049,890.500 JPY th from Dec 2019 (Median) to 2022, with 4 observations. The data reached an all-time high of 19,253,424.000 JPY th in 2019 and a record low of 15,913,943.000 JPY th in 2022. Production Value: Require guidance or OTC Drug: Public Health Drug data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT008: Production Value by Application and Therapeutic Category: Yearly.
| Last | Frequency | Range |
|---|---|---|
| 15,913,943.000 2022 | yearly | 2019 - 2022 |
View Japan's Production Value: Require guidance or OTC Drug: Public Health Drug from 2019 to 2022 in the chart:
Production Value: Require guidance or OTC Drug: Respiratory Organ Agent
Production Value: Require guidance or OTC Drug: Respiratory Organ Agent data was reported at 22,232,538.000 JPY th in 2022. This records an increase from the previous number of 19,496,666.000 JPY th for 2021. Production Value: Require guidance or OTC Drug: Respiratory Organ Agent data is updated yearly, averaging 23,510,547.000 JPY th from Dec 2019 (Median) to 2022, with 4 observations. The data reached an all-time high of 24,973,194.000 JPY th in 2019 and a record low of 19,496,666.000 JPY th in 2021. Production Value: Require guidance or OTC Drug: Respiratory Organ Agent data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT008: Production Value by Application and Therapeutic Category: Yearly.
| Last | Frequency | Range |
|---|---|---|
| 22,232,538.000 2022 | yearly | 2019 - 2022 |
View Japan's Production Value: Require guidance or OTC Drug: Respiratory Organ Agent from 2019 to 2022 in the chart:
Production Value: Require guidance or OTC Drug: Sensory Organ Agent
Production Value: Require guidance or OTC Drug: Sensory Organ Agent data was reported at 90,103,136.000 JPY th in 2022. This records an increase from the previous number of 85,197,887.000 JPY th for 2021. Production Value: Require guidance or OTC Drug: Sensory Organ Agent data is updated yearly, averaging 88,814,500.000 JPY th from Dec 2019 (Median) to 2022, with 4 observations. The data reached an all-time high of 91,126,757.000 JPY th in 2019 and a record low of 85,197,887.000 JPY th in 2021. Production Value: Require guidance or OTC Drug: Sensory Organ Agent data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT008: Production Value by Application and Therapeutic Category: Yearly.
| Last | Frequency | Range |
|---|---|---|
| 90,103,136.000 2022 | yearly | 2019 - 2022 |
View Japan's Production Value: Require guidance or OTC Drug: Sensory Organ Agent from 2019 to 2022 in the chart:
Production Value: Require guidance or OTC Drug: Traditional Chinese Medicines
Production Value: Require guidance or OTC Drug: Traditional Chinese Medicines data was reported at 43,691,357.000 JPY th in 2022. This records an increase from the previous number of 40,457,972.000 JPY th for 2021. Production Value: Require guidance or OTC Drug: Traditional Chinese Medicines data is updated yearly, averaging 40,782,671.000 JPY th from Dec 2019 (Median) to 2022, with 4 observations. The data reached an all-time high of 43,691,357.000 JPY th in 2022 and a record low of 38,289,946.000 JPY th in 2019. Production Value: Require guidance or OTC Drug: Traditional Chinese Medicines data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT008: Production Value by Application and Therapeutic Category: Yearly.
| Last | Frequency | Range |
|---|---|---|
| 43,691,357.000 2022 | yearly | 2019 - 2022 |
View Japan's Production Value: Require guidance or OTC Drug: Traditional Chinese Medicines from 2019 to 2022 in the chart:
Production Value: Require guidance or OTC Drug: Urogenital Organ and Anus Drug
Production Value: Require guidance or OTC Drug: Urogenital Organ and Anus Drug data was reported at 8,481,574.000 JPY th in 2022. This records a decrease from the previous number of 8,952,964.000 JPY th for 2021. Production Value: Require guidance or OTC Drug: Urogenital Organ and Anus Drug data is updated yearly, averaging 8,552,430.000 JPY th from Dec 2019 (Median) to 2022, with 4 observations. The data reached an all-time high of 8,952,964.000 JPY th in 2021 and a record low of 7,699,150.000 JPY th in 2019. Production Value: Require guidance or OTC Drug: Urogenital Organ and Anus Drug data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT008: Production Value by Application and Therapeutic Category: Yearly.
| Last | Frequency | Range |
|---|---|---|
| 8,481,574.000 2022 | yearly | 2019 - 2022 |
View Japan's Production Value: Require guidance or OTC Drug: Urogenital Organ and Anus Drug from 2019 to 2022 in the chart:
Production Value: Require guidance or OTC Drug: Vitamins
Production Value: Require guidance or OTC Drug: Vitamins data was reported at 69,515,229.000 JPY th in 2022. This records a decrease from the previous number of 75,251,979.000 JPY th for 2021. Production Value: Require guidance or OTC Drug: Vitamins data is updated yearly, averaging 74,217,971.500 JPY th from Dec 2019 (Median) to 2022, with 4 observations. The data reached an all-time high of 92,777,510.000 JPY th in 2019 and a record low of 69,515,229.000 JPY th in 2022. Production Value: Require guidance or OTC Drug: Vitamins data remains active status in CEIC and is reported by Ministry of Health, Labour and Welfare. The data is categorized under Global Database’s Japan – Table JP.RT008: Production Value by Application and Therapeutic Category: Yearly.
| Last | Frequency | Range |
|---|---|---|
| 69,515,229.000 2022 | yearly | 2019 - 2022 |